Taken together, these findings support the notion that the ability of FAM3B to promote ESCC progression is, at least in part, dependent on regulation of the AKT–MDM2–p53 pathway and the EMT. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.